VCYT (STOCKS)
Veracyte, Inc.
$49.150000
+1.820000 (+3.85%)
Prev close: $47.330000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Marc A. Stapley
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,924.20M
- Employees
- 824
- P/E (TTM)
- 43.57
- P/B (TTM)
- 2.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
7
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.35 | $0.15 | +0.1999 | +133.18% |
|
Dec 2025 (Q4)
|
$0.51 | $0.22 | +0.2907 | +132.56% |
|
Sep 2025 (Q3)
|
$0.24 | $0.13 | +0.1059 | +78.97% |
|
Jun 2025 (Q2)
|
$-0.01 | $0.10 | -0.1069 | -110.32% |
Financial Statements
| Revenues | $541.74M |
| Benefits Costs and Expenses | $451.00M |
| Cost Of Revenue | $157.56M |
| Costs And Expenses | $306.66M |
| Gross Profit | $384.18M |
| Operating Expenses | $306.66M |
| Research and Development | $80.19M |
| Other Operating Expenses | $226.47M |
| Operating Income/Loss | $77.52M |
| Income/Loss From Continuing Operations After Tax | $88.01M |
| Income/Loss From Continuing Operations Before Tax | $90.75M |
| Income Tax Expense/Benefit | $2.73M |
| Net Income/Loss | $88.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $88.01M |
| Net Income/Loss Available To Common Stockholders, Basic | $88.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.11 |
| Diluted Earnings Per Share | $1.08 |
| Basic Average Shares | 236,853,349 |
| Diluted Average Shares | 240,023,547 |
| Assets | $1.44B |
| Current Assets | $522.18M |
| Noncurrent Assets | $914.23M |
| Intangible Assets | $85.86M |
| Other Non-current Assets | $828.36M |
| Liabilities | $91.99M |
| Current Liabilities | $56.12M |
| Accounts Payable | $6.91M |
| Wages | $18.94M |
| Other Current Liabilities | $30.27M |
| Noncurrent Liabilities | $35.88M |
| Equity | $1.34B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.34B |
| Liabilities And Equity | $1.44B |
| Net Cash Flow From Operating Activities | $166.16M |
| Net Cash Flow From Operating Activities, Continuing | $166.16M |
| Net Cash Flow From Investing Activities | -$85.35M |
| Net Cash Flow From Investing Activities, Continuing | -$85.35M |
| Net Cash Flow From Financing Activities | -$4.37M |
| Net Cash Flow From Financing Activities, Continuing | -$4.37M |
| Exchange Gains/Losses | $587.00K |
| Net Cash Flow | $77.03M |
| Net Cash Flow, Continuing | $76.44M |
| Comprehensive Income/Loss | $108.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $108.43M |
| Other Comprehensive Income/Loss | $108.43M |